Xostem, Inc

xostem is on the leading edge of translational biochemistry, using our stem cell expertise to create the next generation treatment for type 1 diabetes and produce engineered exosomes. our combination of commercially developed science, partnerships with key scientific institutions, and university validation, enables us to rapidly bring to market novel therapies to tangibly improve people’s lives. more applications utilizing our stem cell technology will follow. our engineered exosome science is bringing to market the next generation of exosomes for regenerative skin care, joint care, and other therapies. our research, technology and assays encompass the best methods for exosome isolation, purity, and characterization. more importantly our science leads the new frontier of engineered exosomes that carry well-defined payloads for more successful outcomes. our bioscience device will contain insulin producing cells similar to islets found in a healthy pancreas. our unique encapsulation te